Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $149.6000 (-2.18%) ($148.5400 - $153.7400) on Wed. Mar. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.05% (three month average) | RSI | 49 | Latest Price | $149.6000(-2.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.7% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(22%) XBI(18%) XLV(17%) XOP(17%) XLE(14%) | Factors Impacting ABBV price | ABBV will decline at least -0.525% in a week (0% probabilities). XLC(-13%) BWX(-9%) VXX(-8%) IPO(-8%) XLK(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.525% (StdDev 1.05%) | Hourly BBV | -1.6 () | Intraday Trend | -2.1% | | | |
|
Resistance Level | $152.23 | 5 Day Moving Average | $153.65(-2.64%) | 10 Day Moving Average | $153.64(-2.63%) | 20 Day Moving Average | $152.23(-1.73%) | To recent high | -10.2% | To recent low | 3.5% | Market Cap | $263.937b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |